
Aethlon Medical AEMD
$ 0.76
4.0%
Quarterly report 2025-Q2
added 08-13-2025
Aethlon Medical General and Administrative Expenses 2011-2025 | AEMD
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Aethlon Medical
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.24 M | 3.9 M | 4.48 M | 3.46 M | 2.46 M | 6.58 M | 6.23 M | 4.98 M | 6.49 M | 5.27 M | 4.76 M | 4.68 M | 4.81 M | 4.47 M | 4.56 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
6.58 M | 2.46 M | 4.69 M |
Quarterly General and Administrative Expenses Aethlon Medical
2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
735 K | - | 816 K | 958 K | 752 K | - | 979 K | 851 K | 1.31 M | - | 1.07 M | 1.55 M | 1.03 M | - | 1.11 M | 2.43 M | 1.32 M | - | 921 K | 920 K | 555 K | 409 K | 274 K | 274 K | 342 K | 383 K | 215 K | 215 K | 272 K | - | 136 K | 235 K | 187 K | - | 183 K | 697 K | 514 K | - | 383 K | 994 K | 612 K | - | 467 K | 896 K | 428 K | - | 330 K | 669 K | 339 K | - | 196 K | 563 K | 367 K | - | 384 K | 624 K | 240 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
2.43 M | 136 K | 647 K |
General and Administrative Expenses of other stocks in the Medical devices industry
Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
---|---|---|---|---|---|---|
![]() |
Aziyo Biologics
AZYO
|
14.1 M | $ 1.48 | 1.37 % | $ 20.5 M | ![]() |
![]() |
Natus Medical Incorporated
NTUS
|
52.8 M | $ 31.08 | 1.94 % | $ 1.05 B | ![]() |
![]() |
Dynatronics Corporation
DYNT
|
9.91 M | $ 0.24 | 14.99 % | $ 929 K | ![]() |
![]() |
FONAR Corporation
FONR
|
23.5 M | $ 15.74 | -0.94 % | $ 103 M | ![]() |
![]() |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | $ 3.05 | -5.86 % | $ 30.6 M | ![]() |
![]() |
Cardiovascular Systems
CSII
|
171 M | $ 20.0 | 0.15 % | $ 844 M | ![]() |
![]() |
Neovasc
NVCN
|
14.7 M | $ 30.03 | - | $ 111 M | ![]() |
![]() |
Apollo Endosurgery
APEN
|
20.6 M | $ 10.0 | - | $ 475 M | ![]() |
![]() |
Titan Medical
TMDI
|
12.4 M | $ 0.14 | -26.32 % | $ 19.6 M | ![]() |
![]() |
Viveve Medical
VIVE
|
12.5 M | $ 0.22 | -15.35 % | $ 1.71 M | ![]() |
![]() |
Invacare Corporation
IVC
|
227 M | $ 0.66 | - | $ 24.7 M | ![]() |
![]() |
Abiomed
ABMD
|
334 M | $ 381.02 | - | $ 17.2 B | ![]() |
![]() |
Allied Healthcare Products
AHPI
|
7.11 M | $ 0.55 | 3.58 % | $ 2.21 M | ![]() |
![]() |
CryoLife, Inc.
CRY
|
141 M | $ 17.84 | -4.14 % | $ 702 M | ![]() |
![]() |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | $ 24.04 | - | $ 1.77 B | ![]() |
![]() |
Soliton, Inc.
SOLY
|
8.46 M | $ 20.12 | -1.42 % | $ 435 M | ![]() |
![]() |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | $ 10.38 | -1.98 % | $ 98.3 M | ![]() |
![]() |
Insulet Corporation
PODD
|
466 M | $ 315.49 | 0.65 % | $ 22.1 B | ![]() |
![]() |
Itamar Medical Ltd.
ITMR
|
8.5 M | $ 30.65 | 0.03 % | $ 1.58 B | ![]() |
![]() |
Quanterix Corporation
QTRX
|
90.2 M | $ 6.0 | 6.01 % | $ 226 M | ![]() |
![]() |
Misonix, Inc.
MSON
|
18 M | $ 26.54 | - | $ 462 M | ![]() |
![]() |
Sintx Technologies
SINT
|
4.22 M | $ 4.52 | 7.36 % | $ 16.9 M | ![]() |
![]() |
ShockWave Medical
SWAV
|
95.3 M | $ 334.75 | - | $ 12.3 B | ![]() |
![]() |
SeaSpine Holdings Corporation
SPNE
|
42.9 M | $ 7.16 | 0.28 % | $ 270 M | ![]() |
![]() |
ViewRay
VRAY
|
52.4 M | $ 2.64 | 1.54 % | $ 468 M | ![]() |
![]() |
Intersect ENT, Inc.
XENT
|
98.6 M | $ 28.24 | - | $ 955 M | ![]() |
![]() |
STRATA Skin Sciences
SSKN
|
10.1 M | $ 1.84 | -4.66 % | $ 63.9 M | ![]() |
![]() |
Bruker Corporation
BRKR
|
894 M | $ 34.63 | 0.2 % | $ 5.16 K | ![]() |
![]() |
Axonics Modulation Technologies
AXNX
|
40.2 M | $ 70.98 | - | $ 3.31 B | ![]() |
![]() |
Delcath Systems
DCTH
|
29.6 M | $ 11.1 | 2.78 % | $ 316 M | ![]() |
![]() |
BIOLASE
BIOL
|
10.2 M | $ 0.13 | -13.19 % | $ 166 K | ![]() |
![]() |
Eargo
EAR
|
54.3 M | $ 2.57 | - | $ 10.2 M | ![]() |
![]() |
Viemed Healthcare
VMD
|
87.9 M | $ 6.87 | - | $ 263 M | ![]() |
![]() |
SmileDirectClub
SDC
|
279 M | $ 0.08 | -53.45 % | $ 9.71 M | ![]() |
![]() |
ThermoGenesis Holdings
THMO
|
7.24 M | $ 0.31 | -25.84 % | $ 171 K | ![]() |
![]() |
Acutus Medical
AFIB
|
14.1 M | $ 0.09 | -26.83 % | $ 2.62 M | ![]() |
![]() |
ClearPoint Neuro
CLPT
|
12 M | $ 29.6 | 12.16 % | $ 800 M | ![]() |
![]() |
Surgalign Holdings
SRGA
|
95.9 M | $ 0.18 | -32.98 % | $ 1.68 M | ![]() |
![]() |
Conformis
CFMS
|
28.8 M | $ 2.27 | - | $ 16.4 M | ![]() |
![]() |
Beyond Air
XAIR
|
26 M | $ 2.65 | 8.61 % | $ 179 M | ![]() |
![]() |
Sientra
SIEN
|
31.8 M | $ 0.18 | -16.59 % | $ 10.3 M | ![]() |
![]() |
NuVasive
NUVA
|
634 M | $ 39.75 | - | $ 2.07 B | ![]() |
![]() |
Cutera
CUTR
|
63.3 M | $ 0.1 | -10.19 % | $ 1.99 M | ![]() |
![]() |
Xtant Medical Holdings
XTNT
|
28.7 M | $ 0.68 | 1.3 % | $ 90.9 M | ![]() |
![]() |
Nemaura Medical
NMRD
|
5.6 M | $ 0.11 | -17.8 % | $ 2.74 M | ![]() |
![]() |
Vapotherm
VAPO
|
19.3 M | $ 1.27 | 6.72 % | $ 34 M | ![]() |
![]() |
Talis Biomedical Corporation
TLIS
|
28.2 M | $ 4.38 | 3.55 % | $ 7.96 M | ![]() |
![]() |
Integer Holdings Corporation
ITGR
|
185 M | $ 105.36 | 1.58 % | $ 3.54 B | ![]() |